首页> 外文期刊>European Journal of Obstetrics, Gynecology and Reproductive Biology: An International Journal >Hysteroscopic local anaesthetic intrauterine cornual 'focal local' block before endometrial ablation with direct cervical block in an outpatient setting: A feasibility study
【24h】

Hysteroscopic local anaesthetic intrauterine cornual 'focal local' block before endometrial ablation with direct cervical block in an outpatient setting: A feasibility study

机译:宫腔镜局部麻醉术中子宫内膜角膜“局灶性局部”阻滞在门诊患者子宫内膜消融前直接宫颈阻滞的可行性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objective To evaluate the safety, feasibility and efficacy of a hysteroscopic local anaesthetic intrauterine cornual block (ICOB) on women's perception of pain during outpatient Thermachoice endometrial ablation (TEA). Study design Pre-menopausal women with heavy menstrual bleeding undergoing TEA were included in the study. The intervention used, ICOB, was a hysteroscopic injection of local anaesthetic into the myometrium just medial to each tubal ostium. The women also had a traditional direct cervical block (DCB). We measured the acceptability of ICOB and the pain score (visual analogue score scale) immediately after the procedure. Results We treated 30 patients (mean age 41 years, SD 6; BMI 29 ± 7) between January 2012 and December 2012. All patients had a successful ICOB block and found TEA with ICOB acceptable. The mean VAS score was 3.5 ± 2.7, which was two points lower compared to our earlier prospective cohort of patients undergoing TEA with only a DCB (mean 5.8 ± 2.7, n = 102). No serious complications occurred during the procedure or postoperatively. Three patients experienced a vasovagal response which resolved spontaneously. Conclusion ICOB with DCB is a safe, feasible and efficacious method of pain control during TEA. There is however a need to evaluate efficacy of ICOB in a randomised placebo controlled trial.
机译:目的探讨宫腔镜局部麻醉子宫内角膜阻滞术(ICOB)对妇女在门诊热内膜子宫内膜切除术(TEA)期间疼痛感的安全性,可行性和有效性。研究设计本研究纳入了接受TEA的绝经前出血严重的绝经前妇女。宫腔镜使用宫腔镜将局部麻醉剂注入子宫肌层,正好位于每个输卵管口内侧。这些妇女还患有传统的直接宫颈阻滞(DCB)。手术后,我们立即测量了ICOB的可接受性和疼痛评分(视觉模拟评分量表)。结果我们在2012年1月至2012年12月间共收治了30例患者(平均年龄41岁,SD 6; BMI 29±7)。所有患者均成功完成ICOB阻滞,并发现TEA和ICOB可接受。平均VAS评分为3.5±2.7,与我们之前仅接受DCB的TEA患者的前瞻性队列研究相比,降低了2个百分点(平均5.8±2.7,n = 102)。在手术过程中或术后均未发生严重并发症。三名患者经历了自发性的血管迷走反应。结论ICOB与DCB结合是一种安全,可行,有效的TEA疼痛控制方法。但是,需要在随机安慰剂对照试验中评估ICOB的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号